etoposide has been researched along with afimoxifene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Shapiro, DJ; Yu, DV; Zhou, JH | 1 |
| Farkas, T; Frankel, LB; Høyer-Hansen, M; Jäättelä, M; Krogh, A; Lees, M; Lund, AH; Wen, J | 1 |
2 other study(ies) available for etoposide and afimoxifene
| Article | Year |
|---|---|
Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; CCAAT-Enhancer-Binding Protein-alpha; Estrogen Antagonists; Estrogen Receptor alpha; Etoposide; Gene Expression Profiling; Gene Expression Regulation; HeLa Cells; Humans; Mutation; Oligonucleotide Array Sequence Analysis; RNA, Small Interfering; Tamoxifen | 2007 |
microRNA-101 is a potent inhibitor of autophagy.
Topics: Autophagy; Autophagy-Related Proteins; Breast Neoplasms; Cell Line, Tumor; Cysteine Endopeptidases; Etoposide; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; MicroRNAs; Oligonucleotide Array Sequence Analysis; rab5 GTP-Binding Proteins; RNA Interference; RNA, Small Interfering; Sirolimus; Stathmin; Tamoxifen | 2011 |